welcome Neurology

Find the latest news within neurology here

Specialists Encouraged to Use Cenobamate: A Highly Effective Anti-Seizure Medication for Epilepsy Treatment

December 2024 / Bernhard J. Steinhoff

Epilepsy

Spinraza: Tosielämän näyttö spinaalista lihasatrofiaa (SMA) sairastavista aikuispotilaista

December 2024 / Biogen

Follow news from congresses

EAN

ECTRIMS

See all events

Neurologipäivät 2024

A Step Forward Toward a Global Understanding of MS

December 2024 / Marcello Moccia

MS Neurologipäivät24

The Risk of Alzheimer’s Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

November 2024 / Neurology / Anne Koivisto

Prognostic Factors for Myasthenia Gravis

November 2024 / Neurology / Sini Laakso

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer’s and Dementia

November 2024 / Neurology / Eino Solje

ECTRIMS | Kongres

We cover the most interesting news from the ECTRIMS Congress through abstracts, online articles and MEDtalk videos from experts and specialists worldwide.

EAN | 2024

We cover the most interesting news from the EAN Congress through abstracts, online articles and MEDtalk videos from experts and specialists worldwide.

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.

Find the latest news within neurology here

Specialists Encouraged to Use Cenobamate: A Highly Effective Anti-Seizure Medication for Epilepsy Treatment

Spinraza: Tosielämän näyttö spinaalista lihasatrofiaa (SMA) sairastavista aikuispotilaista

Follow news from congresses

Neurologipäivät 2024

A Step Forward Toward a Global Understanding of MS

The Risk of Alzheimer’s Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

Prognostic Factors for Myasthenia Gravis

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer’s and Dementia

EAN 2025 Will Once Again Be Held in Helsinki

EAN 2024: Highlights Regarding Myasthenia Gravis

Emerging Concepts in Epilepsy: Neurostimulation Techniques, New Drugs and First-Seizure Clinics

New Treatments for Early Alzheimer’s On The Way

New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

The History of Danish Neuroscience

The effects of anti-CD20 therapy on TFH cells in relapsing-remitting MS

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

Poor Sleep Has a Deleterious Impact on Health-Related Quality of Life in People with MS

New Biomarker and Comorbidity Insights in NMOSD and MOGAD

Nationwide Patient-Reported Outcome Portal for MS is Feasible and Provides Clinical Value

MS: This increase in Blood-Brain Barrier Permeability Appears to be Connected to the Spread of Lesions Across the Brain

ECTRIMS | Kongres

EAN | 2024

Name & work area

Find the latest news within neurology here

Follow news from congresses

Neurologipäivät 2024

The Risk of Alzheimer’s Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

Prognostic Factors for Myasthenia Gravis

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer’s and Dementia

EAN 2024

EAN 2025 Will Once Again Be Held in Helsinki

EAN 2024: Highlights Regarding Myasthenia Gravis

Emerging Concepts in Epilepsy: Neurostimulation Techniques, New Drugs and First-Seizure Clinics

New Treatments for Early Alzheimer’s On The Way

New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

The History of Danish Neuroscience

ECTRIMS 2024

The effects of anti-CD20 therapy on TFH cells in relapsing-remitting MS

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

Poor Sleep Has a Deleterious Impact on Health-Related Quality of Life in People with MS

New Biomarker and Comorbidity Insights in NMOSD and MOGAD

Nationwide Patient-Reported Outcome Portal for MS is Feasible and Provides Clinical Value

MS: This increase in Blood-Brain Barrier Permeability Appears to be Connected to the Spread of Lesions Across the Brain

ECTRIMS | Kongres

EAN | 2024

More from neurology